Cyclic antibiotic therapy for diverticular disease: A critical reappraisal

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 3, 2010, Pages 295-302

  Zullo, Angelo ^a   Hassan, Cesare ^a   Maconi, Giovanni ^b   Manes, Gianpiero ^b   Tammaro, Gianfranco ^c   de Francesco, Vincenzo ^d   Annibale, Bruno ^e   Ficano, Leonardo ^f   Buri, Luigi ^g   Gatto, Giovanni ^h   Lorenzetti, Roberto ^a   Campo, Salvatore M ^a   Ierardi, Enzo ^d   Pace, Fabio ⁱ   Morini, Sergio ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g UNIVERSITY OF TRIESTE   (Italy)

^h Villa Sofia Hospital Palermo   (Romania)

ⁱ BOLOGNINI HOSPITAL   (Italy)

Author keywords

Diverticular disease; Diverticulitis; Haemorrhage; Rifaximin; Symptoms; Therapy

Indexed keywords

MANNAN; MESALAZINE; NEOMYCIN; PAROMOMYCIN; PLACEBO; RIFAXIMIN;

ABSCESS; ANGIOGRAPHY; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DIVERTICULOSIS; DRUG MECHANISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INTESTINE FISTULA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; OTOTOXICITY; PATIENT COMPLIANCE; PREVALENCE; QUALITY OF LIFE; REVIEW; SCINTIGRAPHY; SCORING SYSTEM;

ANTI-BACTERIAL AGENTS; DIETARY FIBER; DIVERTICULITIS; DIVERTICULUM; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; RIFAMYCINS; TREATMENT OUTCOME;

EID: 78650168246     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Martel J, Raskin JB. History, incidence, and epidemiology of diverticulosis. J Clin Gastroenterol 2008; 42:1125-1127.
2. Colecchia A, Sandri L, Capodicasa S, et al. Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003;9:1385-1389.
3. Stollman N, Raskin JB. Diverticular disease of the colon. Lancet 2004;363:631-639.
4. Sheth AA, Longo W, Floch MH. Diverticular disease and diverticulitis. Am J Gastroenterol 2008; 103:1550-1556.
5. Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamanga G. Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther 2006; 23:1379-1391.
6. Clemens CH, Samsom M, Roelofs J, van Berge Henegouwen GP, Smout AJ. Colorectal visceral perception in diverticular disease. Gut 2004;53: 717-722.
7. Otte JJ, Larsen L, Andersen JR. Irritable bowel syndrome and symptomatic diverticular disease - different diseases? Am J Gastroenterol 1986;81:529-531.
8. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-661.
9. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs 2009;18:349-358.
10. Latella G, Scarpignato C. Rifaximin in the management of colonic diverticular disease. Expert Rev Gastroenterol Hepatol 2009;3:585-589.
11. Ojetti V, Lauritano EC, Barbaro F, et al. Rifaximin pharmacology and clinical implications. Expert Opin Drug Metab Toxicol 2009;5:675-682.
12. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010;26:17-25.
13. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995;9:33-39.
14. Latella G, Pimpo MT, Sottili S, et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003;18:55-62.
15. Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007;13:264-269.
16. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 1992;24:452-456.
17. Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci 2007;52: 2934-2941.
18. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005;17:332-340.
19. Scherl EJ, Pruitt R, Gordon GL, et al. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Am J Gastroenterol 2009;104:1452-1459.
20. Celasco G, Papa A, Jones R, et al. Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis. Aliment Pharmacol Ther 2010;31:375-386.
21. Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006;23:1117-1125.
22. Jacobs DO. Clinical practice. Diverticulitis. N Eng J Med 2007;357:2057-2066.
23. Rao PM, Rhea JT, Novelline RA, et al. Helical CT with only colonic contrast material for diagnosing diverticulitis: prospective evaluation of 150 patients. AJR Am J Roentgenol 1998;170:1445-1449.
24. Lahat A, Menachem Y, Avidan B, et al. Diverticulitis in the young patient: is it different? World J Gastroenterol 2006;12:2932-2935.
25. Lahat A, Yanai H, Sakhnini E, Menachem Y, Bar-Meir S. Role of colonoscopy in patients with persistent acute diverticulitis. World J Gastroenterol 2008;14:2763-2766.
26. Simpson J, Neal KR, Scholefield JH, Spiller RC. Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol 2003;15:1005-1010.
27. Jensen DM, Machicado GA, Jutabha R, Kovacs TO. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med 2000;342:78-82.
28. Tursi A. Diverticular disease: what is the best long-term treatment? Nat Rev Gastroenterol Hepatol 2010;7:77-78.
29. Agrawal A, Whorwell PJ. Review article: abdominal bloating and distension in functional gastrointestinal disorders - epidemiology and exploration of possible mechanisms. Aliment Pharmacol Ther 2008;27:2-10.
30. Scarpignato C, Pelosini I. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion 2006;73 (suppl 1):13-27.
31. D'Incà R, Pomerri F, Vettorato MG, et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 2007;25:771-779.
32. Morini S, Zullo A, Hassan C, Tomao S, Campo SM. Diverticulosis and colorectal cancer: between lights and shadows. J Clin Gastroenterol 2008;42:763-770.
33. Comparato G, Fanigliulo L, Aragona G, et al. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis 2007;25:252-259.
34. Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 1992;33:818-824.
35. Bellini M, Bove A, Sormani MP, et al. The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. Dig Liver Dis 2010; 42:99-102.
36. Almy TP, Howell DA. Medical progress. Diverticular disease of the colon. N Engl J Med 1980;302:324-331.
37. Szojda MM, Cuesta MA, Mulder CM, Felt-Bersma RJ. Review article: Management of diverticulitis. Aliment Pharmacol Ther 2007;26 (Suppl 2):67-76.
38. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563.